← Evidence map

ArticleBiomaterials2022

Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells.

Zhenghu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34801254